BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ramakrishnan S, Steck SE, Arab L, Zhang H, Bensen JT, Fontham ETH, Johnson CS, Mohler JL, Smith GJ, Su LJ, Woloszynska A. Association among plasma 1,25(OH)2 D, ratio of 1,25(OH)2 D to 25(OH)D, and prostate cancer aggressiveness. Prostate 2019;79:1117-24. [PMID: 31077420 DOI: 10.1002/pros.23824] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Campolina-Silva GH, Barata MC, Werneck-Gomes H, Maria BT, Mahecha GAB, Belleannée C, Oliveira CA. Altered expression of the vitamin D metabolizing enzymes CYP27B1 and CYP24A1 under the context of prostate aging and pathologies. J Steroid Biochem Mol Biol 2021;209:105832. [PMID: 33596463 DOI: 10.1016/j.jsbmb.2021.105832] [Reference Citation Analysis]
2 Toribio MJ, Priego-Capote F, Pérez-Gómez B, Fernández de Larrea-Baz N, Ruiz-Moreno E, Castelló A, Lucas P, Sierra MÁ, Pino MN, Martínez-Cortés M, Luque de Castro MD, Lope V, Pollán M. Factors Associated with Serum Vitamin D Metabolites and Vitamin D Metabolite Ratios in Premenopausal Women. Nutrients 2021;13:3747. [PMID: 34836003 DOI: 10.3390/nu13113747] [Reference Citation Analysis]
3 Yu X, Liu B, Zhang N, Wang Q, Cheng G. Immune Response: A Missed Opportunity Between Vitamin D and Radiotherapy. Front Cell Dev Biol 2021;9:646981. [PMID: 33928081 DOI: 10.3389/fcell.2021.646981] [Reference Citation Analysis]
4 Negri M, Gentile A, de Angelis C, Montò T, Patalano R, Colao A, Pivonello R, Pivonello C. Vitamin D-Induced Molecular Mechanisms to Potentiate Cancer Therapy and to Reverse Drug-Resistance in Cancer Cells. Nutrients 2020;12:E1798. [PMID: 32560347 DOI: 10.3390/nu12061798] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
5 Ramakrishnan S, Steck SE, Arab L, Zhang H, Bensen JT, Fontham ETH, Johnson CS, Mohler JL, Smith GJ, Su LJ, Woloszynska A. Association among plasma 1,25(OH)2 D, ratio of 1,25(OH)2 D to 25(OH)D, and prostate cancer aggressiveness. Prostate 2019;79:1117-24. [PMID: 31077420 DOI: 10.1002/pros.23824] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
6 Carretero-González A, Lora D, Manneh R, Lorente D, Castellano D, de Velasco G. Combination of statin/vitamin D and metastatic castration-resistant prostate cancer (CRPC): a post hoc analysis of two randomized clinical trials. Clin Transl Oncol 2020;22:2126-9. [PMID: 32198642 DOI: 10.1007/s12094-020-02334-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
7 McCray T, Pacheco JV, Loitz CC, Garcia J, Baumann B, Schlicht MJ, Valyi-Nagy K, Abern MR, Nonn L. Vitamin D sufficiency enhances differentiation of patient-derived prostate epithelial organoids. iScience 2021;24:101974. [PMID: 33458620 DOI: 10.1016/j.isci.2020.101974] [Reference Citation Analysis]
8 Huang R, Xiang J, Zhou P. Vitamin D, gut microbiota, and radiation-related resistance: a love-hate triangle. J Exp Clin Cancer Res 2019;38:493. [PMID: 31843023 DOI: 10.1186/s13046-019-1499-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]